Matches in SemOpenAlex for { <https://semopenalex.org/work/W2680456958> ?p ?o ?g. }
- W2680456958 endingPage "4709" @default.
- W2680456958 startingPage "4697" @default.
- W2680456958 abstract "Abstract Evolution of tumor cell phenotypes promotes heterogeneity and therapy resistance. Here we found that induction of CD73, the enzyme that generates immunosuppressive adenosine, is linked to melanoma phenotype switching. Activating MAPK mutations and growth factors drove CD73 expression, which marked both nascent and full activation of a mesenchymal-like melanoma cell state program. Proinflammatory cytokines like TNFα cooperated with MAPK signaling through the c-Jun/AP-1 transcription factor complex to activate CD73 transcription by binding to an intronic enhancer. In a mouse model of T-cell immunotherapy, CD73 was induced in relapse melanomas, which acquired a mesenchymal-like phenotype. We also detected CD73 upregulation in melanoma patients progressing under adoptive T-cell transfer or immune checkpoint blockade, arguing for an adaptive resistance mechanism. Our work substantiates CD73 as a target to combine with current immunotherapies, but its dynamic regulation suggests limited value of CD73 pretreatment expression as a biomarker to stratify melanoma patients. Cancer Res; 77(17); 4697–709. ©2017 AACR." @default.
- W2680456958 created "2017-06-30" @default.
- W2680456958 creator A5000038661 @default.
- W2680456958 creator A5008698954 @default.
- W2680456958 creator A5010759010 @default.
- W2680456958 creator A5012137496 @default.
- W2680456958 creator A5015796348 @default.
- W2680456958 creator A5020280065 @default.
- W2680456958 creator A5025785991 @default.
- W2680456958 creator A5030018577 @default.
- W2680456958 creator A5034365278 @default.
- W2680456958 creator A5040207559 @default.
- W2680456958 creator A5043373712 @default.
- W2680456958 creator A5044221013 @default.
- W2680456958 creator A5051141861 @default.
- W2680456958 creator A5054642059 @default.
- W2680456958 creator A5061575707 @default.
- W2680456958 creator A5071577704 @default.
- W2680456958 creator A5073616355 @default.
- W2680456958 creator A5073940249 @default.
- W2680456958 creator A5078324938 @default.
- W2680456958 creator A5081677088 @default.
- W2680456958 creator A5083653505 @default.
- W2680456958 creator A5083745558 @default.
- W2680456958 date "2017-08-31" @default.
- W2680456958 modified "2023-09-30" @default.
- W2680456958 title "MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy" @default.
- W2680456958 cites W1834835434 @default.
- W2680456958 cites W1950829641 @default.
- W2680456958 cites W1965370740 @default.
- W2680456958 cites W1974409640 @default.
- W2680456958 cites W1987534017 @default.
- W2680456958 cites W1990602451 @default.
- W2680456958 cites W2001348339 @default.
- W2680456958 cites W2004704417 @default.
- W2680456958 cites W2005647807 @default.
- W2680456958 cites W2008322756 @default.
- W2680456958 cites W2018433132 @default.
- W2680456958 cites W2023186669 @default.
- W2680456958 cites W2039123767 @default.
- W2680456958 cites W2049601932 @default.
- W2680456958 cites W2052005627 @default.
- W2680456958 cites W2054661897 @default.
- W2680456958 cites W2060691656 @default.
- W2680456958 cites W2072022331 @default.
- W2680456958 cites W2080641261 @default.
- W2680456958 cites W2084472730 @default.
- W2680456958 cites W2094481139 @default.
- W2680456958 cites W2097227099 @default.
- W2680456958 cites W2102448788 @default.
- W2680456958 cites W2106190040 @default.
- W2680456958 cites W2110466396 @default.
- W2680456958 cites W2127956110 @default.
- W2680456958 cites W2128685355 @default.
- W2680456958 cites W2131040858 @default.
- W2680456958 cites W2134471382 @default.
- W2680456958 cites W2142857044 @default.
- W2680456958 cites W2144174481 @default.
- W2680456958 cites W2158416296 @default.
- W2680456958 cites W2160141570 @default.
- W2680456958 cites W2166662937 @default.
- W2680456958 cites W2186855780 @default.
- W2680456958 cites W2214074259 @default.
- W2680456958 cites W2223596045 @default.
- W2680456958 cites W2266408649 @default.
- W2680456958 cites W2299181842 @default.
- W2680456958 cites W2317673718 @default.
- W2680456958 cites W2318400076 @default.
- W2680456958 cites W2332292689 @default.
- W2680456958 cites W2337084923 @default.
- W2680456958 cites W2395676613 @default.
- W2680456958 cites W2465860350 @default.
- W2680456958 cites W2474535137 @default.
- W2680456958 cites W2513498397 @default.
- W2680456958 cites W2519184848 @default.
- W2680456958 cites W2522954633 @default.
- W2680456958 cites W2554682097 @default.
- W2680456958 cites W2557336488 @default.
- W2680456958 cites W2558219863 @default.
- W2680456958 cites W2577256604 @default.
- W2680456958 doi "https://doi.org/10.1158/0008-5472.can-17-0395" @default.
- W2680456958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28652246" @default.
- W2680456958 hasPublicationYear "2017" @default.
- W2680456958 type Work @default.
- W2680456958 sameAs 2680456958 @default.
- W2680456958 citedByCount "123" @default.
- W2680456958 countsByYear W26804569582017 @default.
- W2680456958 countsByYear W26804569582018 @default.
- W2680456958 countsByYear W26804569582019 @default.
- W2680456958 countsByYear W26804569582020 @default.
- W2680456958 countsByYear W26804569582021 @default.
- W2680456958 countsByYear W26804569582022 @default.
- W2680456958 countsByYear W26804569582023 @default.
- W2680456958 crossrefType "journal-article" @default.
- W2680456958 hasAuthorship W2680456958A5000038661 @default.
- W2680456958 hasAuthorship W2680456958A5008698954 @default.
- W2680456958 hasAuthorship W2680456958A5010759010 @default.
- W2680456958 hasAuthorship W2680456958A5012137496 @default.